IP Library Granted Patent US 7,767,701
Granted Patent B2
US 7,767,701 · App. 10/535,690 · Granted Aug 3, 2010

Chemical compounds

Assignee: GlaxoSmithKline LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,767,701
App. No.
10/535,690
Granted
Aug 3, 2010
Kind
B2
Abstract

This invention relates to newly identified compounds for inhibiting hYAK3 proteins and methods for treating diseases associated with the imbalance or inappropriate activity of hYAK3 proteins.

Claims (160)

1. A compound of the formula II, or a salt thereof,

in which

R is C 3-6 cycloalkyl or naphthyl; or

R is

in which R1 is hydrogen, halogen, —C 1-6 alkyl, —SC 1-6 alkyl, —OC 1-6 alkyl, —NO 2 , —S(═O)—C 1-6 alkyl, —OH, —CF 3 , —CN, —CO 2 H, —OCF 3 , or —CO 2 C 1-6 alkyl;

and R2 and R3 are independently hydrogen, halogen, —C 1-6 alkyl, —SC 1-6 alkyl, —CO 1-6 alkyl, —NO 2 , —S(═O)—C 1-6 alkyl, —OH, —CF 3 , —CN, —CO 2 H, —CO 2 C 1-6 alkyl, —CONH 2 , —NH 2 , —OCH 2 (C═O)OH, —OCH 2 CH 2 OCH 3 , —SO 2 NH 2 , —CH 2 SO 2 CH 3 , —NH(C═NH)CH 3 ; or R2 and R3 can independently be a radical of the formula

R is

in which q is one or two; R4 is hydrogen, halogen, or —SO 2 NH 2 ; or

R is (CH 2 )—NR k R l in which n is 2 or 3, and R k and R l are independently —C 1-6 alkyl; or —NR k R l together form

R is

Q is

in which R5 is hydrogen, phenyl optionally substituted with up to three C 1-6 alkyl or halogen, or C 1-6 alkyl; or

Q is

in which Y is CH; and A and B together are a part of

provided that ortho position to Y is N or O.

2. A compound of formula II as described in claim 1 in which

R is C 3-6 cycloalkyl or naphthyl; or

R is

in which R1 is hydrogen, halogen, —C 1-6 alkyl, —SC 1-6 alkyl, —OC 1-6 alkyl, —NO 2 , —S(═O)—C 1-6 alkyl, —OH, —CF 3 , —CN, —CO 2 H, —OCF 3 , or —CO 2 C 1-6 alkyl;

and R2 and R3 are independently hydrogen, halogen, —C 1-6 alkyl, —SC 1-6 alkyl, —OC 1-6 alkyl, —NO 2 , —S(═O)—C 1-6 alkyl, —OH, —CF 3 , —CN, —CO 2 H, —CO 2 C 1-6 alkyl, —CONH 2 , —NH 2 , —OCH 2 (C═O)OH, —OCH 2 CH 2 OCH 3 , —SO 2 NH 2 , —CH 2 SO 2 CH 3 , —NH(C═NH)CH 3 ; or R2 and R3 can independently be a radical of the formula

R is

in which q is one or two; R4 is hydrogen, halogen, or —SO 2 NH 2 ; or

R is (CH 2 )—NR k R l in which n is 2 or 3, and R k and R l are independently —C 1-6 alkyl; or NR k R l together form

R is

Q is

in which R5 is hydrogen, phenyl optionally substituted with up to three C 1-6 alkyl or halogen, or C 1-6 alkyl; or

Q is

in which Y is CH; and A and B together are a part of

provided that ortho position to Y is N or O, or a salt thereof.

3. A compound of formula II as described in claim 2 in which R is

in which R1 is halogen, —C 1-6 alkyl, —SC 1-6 alkyl, —OC 1-6 alkyl, —NO 2 , —S(═O)—C 1-6 alkyl, —OH, —CF 3 , —CN, —CO 2 H, or —CO 2 C 1-6 alkyl;

and R2 and R3 are independently hydrogen, halogen, —C 1-6 alkyl, —SC 1-6 alkyl, —OC 1-6 alkyl, —NO 2 , —S(═O)—C 1-6 alkyl, —OH, —CF 3 , —CN, —CO 2 H, —CO 2 C 1-6 alkyl, —NH 2 , or —NH(C═NH)CH 3 ;

and

Q is

Q is

in which Y is CH; and A and B together are a part of

provided that ortho position to Y is N or O, or a salt thereof.

4. A compound of formula II as described in claim 3 in which R is

in which R1 is halogen, —C 1-6 alkyl, —SC 1-6 alkyl, —OC 1-6 alkyl, —NO 2 , —S(═O)—C 1-6 alkyl, —OH, —CF 3 , —CN, —CO 2 H, or —CO 2 C 1-6 alkyl;

and R2 and R3 are independently hydrogen, halogen, —C 1-6 alkyl, —SC 1-6 alkyl, —OC 1-6 alkyl, —NO 2 , —S(═O)—C 1-6 alkyl, —OH, —CF 3 , —CN, —CO 2 H, —CO 2 C 1-6 alkyl, —NH 2 , or —NH(C═NH)CH 3 ;

and

Q is

Q is

in which Y is CH; and A and B together are a part of

provided that ortho position to Y is N or O, or a salt thereof.

5. A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 1 or a salt thereof and one or more of pharmaceutically acceptable carriers, diluents and excipients.

6. A compound of claim 1 selected from the group consisting of:

2-(2-Chloro-5-fluoro-phenylimino)-5-(2,3-dihydro-benzo[1-6]dioxin-6-ylmethylene)-thiazolidin-4-one;

2-(2-Chloro-phenylimino)-5-(2-oxo-2H-chromen-6-ylmethylene)-thiazolidin-4-one;

2-(2-Chloro-phenylimino)-5-(2-oxo-2H-chromen-6-ylmethylene)-thiazolidin-4-one;

2-(2-Chloro-phenylimino)-5-(2-oxo-2H-chromen-6-ylmethylene)-thiazolidin-4-one;

5-(2,3-Dihydro-benzofuran-5-ylmethylene)-2-(2,4,6-trimethyl-phenylimino)-thiazolidin-4-one;

2-Cyclohexylimino-5-(2,3-dihydro-benzo[1-6]dioxin-6-ylmethylene)-thiazolidin-4-one;

2-Cyclohexylimino-5-(2,3-dihydro-benzofuran-5-ylmethylene)-thiazolidin-4-one;

5-(2,3-Dihydro-benzofuran-5-ylmethylene)-2-o-totylimino-thiazolidin-4-one;

5-(2,3-Dihydro-benzo[1-6]dioxin-6-ylmethylene)-2-o-tolylimino-thiazolidin-4-one;

5-[2-(2-Chloro-phenylimino)-4-oxo-thiazolidin-5-ylidenemethyl]-3H-benzooxazol-2-one;

2-(2-Trifluoromethyl-phenylimino)-5-(2,3-dihydro-benzofuran-5-ylmethylene)-thiazolidin-4-one;

2-(2-Bromo-phenylimino)-5-(2,3-dihydro-benzofuran-5-ylmethylene)-thiazolidin-4-one;

2-(2,6-Dichloro-phenylimino)-5-(2,3-dihydro-benzofuran-5-ylmethylene)-thiazolidin-4-one;

5-(2,3-Dihydro-benzofuran-5-ylmethylene)-2-(2-methylsulfanyl-phenylimino)-thiazolidin-4-one;

5-(2,3-Dihydro-benzofuran-5-ylmethylene)-2-(2-fluoro-phenylimino)-thiazolidin-4-one;

2-(2-Methylsulfanyl-phenylimino)-5-(quinolin-6-ylmethylene)-thiazolidin-4-one;

2-(2-Bromo-phenylimino)-5-(quinolin-6-ylmethylene)-thiazolidin-4-one;

2-(2,3-Dimethyl-phenylimino)-5-(quinolin-6-ylmethylene)-thiazolidin-4-one;

2-(Naphthalen-1-ylimino)-5-(quinolin-6-ylmethylene)-thiazolidin-4-one;

5-(Quinolin-6-ylmethylene)-2-(2-trifluoromethyl-phenylimino)-thiazolidin-4-one;

2-(2-Chloro-5-trifluoromethyl-phenylimino)-5-(quinolin-6-ylmethylene)-thiazolidin-4-one;

2-(2,6-Dichloro-phenylimino)-5-8quinolin-6-ylmethylene)-thiazolidin-4-one;

2-(2-Bromo-phenylimino)-5-(2,3-dihydro-benzo[1-6]dioxin-6-ylmethylene)-thiazolidin-4-one;

2-(2-Chloro-phenylimino)-5-(quinoxalin-6-ylmethylene)-thiazolidin-4-one;

2-(2,6-Dichloro-phenylimino)-5-(2,3-dihydro-benzo[1-6]dioxin-6-ylmethylene)-thiazolidin-4-one;

5-(2,3-Dihydro-benzo[1-6]dioxin-6-ylmethylene)-2-(2-nitro-phenylimino)-thiazolidin-4-one;

5-(2,3-Dihydro-benzofuran-5-ylmethylene)-2-(2-nitro-phenylimino)-thiazolidin-4-one;

2-(2-Chloro-4-fluoro-5-methyl-phenylimino)-5-(2,3-dihydro-benzofuran-5-ylmethylene)-thiazolidin-4-one;

3-Chloro-4-[5-(2,3-dihydro-benzofuran-5-ylmethylene)-4-oxo-thiazolidin-2-ylideneamino]-benzoic acid methyl ester;

2-(2-Chloro-5-fluoro-phenylimino)-5-(2,3-dihydro-benzofuran-5-ylmethylene)-thiazolidin-4-one;

2-(2-Chloro-4-trifluoromethyl-phenylimino)-5-(2,3-dihydro-benzofuran-5-ylmethylene)-thiazolidin-4-one;

2-(4-Bromo-2-chloro-phenylimino)-5-(2,3-dihydro-benzofuran-5-ylmethylene)-thiazolidin-4-one;

5-(2,3-Dihydro-benzofuran-5-ylmethylene)-2-(2-methanesulfinyl-phenylimino)-thiazolidin-4-one;

3-Chloro-4-[5-(2,3-dihydro-benzofuran-5-ylmethylene)-4-oxo-thiazolidin-2-ylideneamino]-benzoic acid;

5-[2-(2-Chloro-phenylimino)-4-oxo-thiazolidin-5-ylidenemethyl]-1H-pyridin-2-one;

2-(2-Methylsulfanyl-phenylimino)-5-(quinolin-6-ylmethylene)-thiazolidin-4-one;

2-(2-Chloro-4-fluoro-5-methyl-phenylimino)-5-(quinolin-6-ylmethylene)-thiazolidin-4-one;

2-(2-Chloro-5-fluoro-phenylimino)-5-(quinolin-6-ylmethylene)-thiazolidin-4-one;

2-(2-Chloro-5-fluoro-phenylimino)-5-(2,3-dihydro-benzo[1-6]dioxin-6-ylmethylene)-thiazolidin-4-one;

2-(2-Chloro-4-trifluoromethyl-phenylimino)-5-quinolin-6-ylmethylene-thiazolidin-4-one;

5-(Benzothiazol-6-ylmethylene)-2-(2-chloro-phenylimino)-thiazolidin-4-one;

5-(Benzo[1,2,5]thiadiazol-5-ylmethylene)-2-(2-bromo-phenylimino)-thiazolidin-4-one;

5-(Benzo[1,2,5]thiadiazol-5-ylmethylene)-2-(2-chloro-5-fluoro-phenylimino)-thiazolidin-4-one;

5-(Benzothiazol-6-ylmethylene)-2-(2,6-dichloro-phenylimino)-thiazolidin-4-one;

2-(2-Chloro-phenylimino)-5-(4-hydroxy-3-nitro-benzylidene)-thiazolidin-4-one;

2-(2-Chloro-phenylimino)-5-(4-hydroxy-3-methoxy-benzylidene)-thiazolidin-4-one;

2-(2-Chloro-phenylimino)-5-(4-hydroxy-benzylidene)-thiazolidin-4-one;

2-(2-Chloro-phenylimino)-5-(4-methoxy-benzylidene)-thiazolidin-4-one;

5-(3-Chloro-4-hydroxy-benzylidene)-2-(2-chloro-phenylimino)-thiazolidin-4-one;

2-(2-Chloro-phenylimino)-5-(3-fluoro-4-methoxy-benzylidene)-thiazolidin-4-one;

2-(2,6-Dichloro-phenylimino)-5-(3-fluoro-4-hydroxy-benzylidene)-thiazolidin-4-one;

2-(2-Chloro-phenylimino)-5-(3-fluoro-4-hydroxy-benzylidene)-thiazolidin-4-one;

2-(2-Chloro-5-fluoro-phenylimino)-5-(3-fluoro-4-hydroxy-benzylidene)-thiazolidin-4-one;

5-(3-Fluoro-4-hydroxy-benzylidene)-2-o-tolylimino-thiazolidin-4-one;

2-(2-Chloro-phenylimino)-5-quinolin-6-ylmethylene-thiazolidin-4-one;

5-Quinolin-6-ylmethylene-2-(2,4,6-trimethyl-phenylimino)-thiazolidin-4-one;

5-Quinolin-6-ylmethylene-2-o-tolylimino-thiazolidin-4-one;

2-(2-Methoxy-phenylimino)-5-quinolin-6-ylmethylene-thiazolidin-4-one;

5-(213-Dihydro-benzofuran-5-ylmethylene)-2-(2-dimethylamino-ethylamino)-thiazol-4-one;

Benzoic acid N′-(4-oxo-5-quinolin-6-ylmethylene-4,5-dihydro-thiazol-2-yl)-hydrazide;

2-(2-Dimethylamino-ethylimino)-5-quinolin-6-ylmethylene-thiazolidin-4-one;

5-(2,3-Dihydro-benzofuran-5-ylmethylene)-2-(piperidin-1-ylamino)-thiazol-4-one;

2-Benzylamino-5-(2,3-dihydro-benzofuran-5-ylmethylene)-thiazol-4-one;

2-(4-tert-Butyl-thiazol-2-ylamino)-5-(2,3-dihydro-benzofuran-5-ylmethylene)-thiazol-4-one;

4-{[5-(2,3-Dihydro-benzofuran-5-ylmethylene)-4-oxo-4,5-dihydro-thiazol-2-ylamino]-methyl}-benzenesulfonamide;

5-(2,3-Dihydro-benzofuran-5-ylmethylene)-2-(3-dimethylamino-propylamino)-thiazol-4-one;

5-(23-Dihydro-benzofuran-5-ylmethylene)-2-(3-imidazol-1-yl-propylamino)-thiazol-4-one;

Phenyl-carbamic acid N′-[5-(2,3-dihydro-benzofuran-5-ylmethylene)-4-oxo-4,5-dihydro-thiazol-2-yl]-hydrazide;

Benzoic acid N′-[5-(2,3-dihydro-benzofuran-5-ylmethylene)-4-oxo-4,5-dihydro-thiazol-2-yl]-hydrazide;

5-Benzo[1,2,5]thiadiazol-5-ylmethylene-2-(2,3,4-trifluoro-phenylamino)-thiazol-4-one;

5-Benzo[1,2,5]oxadiazol-5-ylmethylene-2-(2-nitro-phenylamino)-thiazol-4-one;

2-(2,6-Dichloro-phenylamino)-5-(4-[1,2,4]triazol-1-yl-benzylidene)-thiazol-4-one;

2-(2,6-Dichloro-phenylamino)-5-(1H-pyrrolo[2,3-b]pyridin-2-ylmethylene)-thiazol-4-one;

5-Benzo[1,2,5]thiadiazol-5-ylmethylene-2-(2,6-dichloro-phenylamino)-thiazol-4-one;

5-[2-(2-Methoxy-6-methyl-phenylamino)-4-oxo-4H-thiazol-5-ylidenemethyl]-1H-pyridin-2-one;

5-Benzo[1,2,5]thiadiazol-5-ylmethylene-2-(2-nitro-phenylamino)-thiazol-4-one;

2-(2-Bromo-6-fluoro-phenylamino)-5-quinolin-6-ylmethylene-thiazol-4-one;

2-(2-Methoxy-6-methyl-phenylamino)-5-quinolin-6-ylmethylene-thiazol-4-one;

5-Quinolin-6-ylmethylene-2-(2,3,4-trifluoro-phenylamino)-thiazol-4-one;

2-(2,6-Dichloro-phenylamino)-5-(2-oxo-2H-chromen-6-ylmethylene)-thiazol-4-one;

2-(2-Bromo-phenylamino)-5-(5-pyridin-2-yl-thiophen-2-ylmethylene)-thiazol-4-one;

2-(2-Bromo-phenylamino)-5-(1-oxy-pyridin-4-ylmethylene)-thiazol-4-one;

2-(2-Bromo-phenylamino)-5-(3-p-tolyl-benzo[c]isoxazol-5-ylmethylene)-thiazol-4-one;

2-(2-Bromo-phenylamino)-5-(3,4-dihydro-2H-benzo[b][1-6]dioxepin-7-ylmethylene)-thiazol-4-one;

5-Benzo[1,2,5]oxadiazol-5-ylmethylene-2-(2-bromo-phenylamino)-thiazol-4-one;

2-(2,6-Dichloro-phenylamino)-5-(2-methoxy-pyridin-3-ylmethylene)-thiazol-4-one;

2-(2-Chloro-phenylamino)-5-(6-methoxy-pyridin-3-ylmethylene)-thiazol-4-one;

2-(2-Chloro-5-trifluoromethyl-phenylamino)-5-quinolin-6-ylmethylene-thiazol-4-one;

2-(2-Bromo-phenylamino)-5-(4-hydroxy-3-methoxy-benzylidene)-thiazol-4-one;

5-(2,3-Dihydro-benzofuran-5-ylmethylene)-2-(2-methoxy-phenylamino)-thiazol-4-one;

2-(2-Nitro-phenylamino)-5-quinolin-6-ylmethylene-thiazol-4-one

2-(2-Bromo-phenylamino)-5-(3,4-diamino-benzylidene)-thiazol-4-one;

5-[2-(2-Chloro-phenylimino)-4-oxo-thiazolidin-5-ylidenemethyl]-1-methyl-1H-pyridin-2-one;

2-(2-Chloro-5-nitro-phenylamino)-5-quinolin-6-ylmethylene-thiazol-4-one;

2-(5-Amino-2-chloro-phenylamino)-5-quinolin-6-ylmethylene-thiazol-4-one;

N-[4-Chloro-3-(4-oxo-5-quinolin-6-ylmethylene-4,5-dihydro-thiazol-2-ylamino)-phenyl]-acetamidine hydrochloride;

4-{[4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}benzamide;

3-{[4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}benzenesulfonamide;

4-{[4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}-N-2-pyridinylbenzenesulfonamide;

2-({4-[(4-methyl-1-piperazinyl)methyl]phenyl}amino)-5-(6-quinolinylmethylidene)-1,3-thiazol-4(5H)-one;

2-({4-[(methylsulfonyl)methyl]phenyl}amino)-5-(6-quinolinylmethylidene)-1,3-thiazol-4(5H)-one;

2-({3-[(methylsulfonyl)methyl]phenyl}amino)-5-(6-quinolinylmethylidene)-1,3-thiazol-4(5H)-one;

2-{[4-(4-methyl-1-piperazinyl)phenyl]amino}5-(6-quinolinylmethylidene)-1,3-thiazol-4(5H)-one;

2-{[2-(3-chlorophenyl)ethyl]amino}-5-(6-quinolinylmethylidene)-1,3-thiazol-4(5H)-one;

4-(2-{[4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}ethyl)benzenesulfonamide;

3-{[4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}benzamide;

2-[(2,6-Difluoro-phenylamino)-methylene]-5-quinolin-6-ylmethylene-thiazolidin-4-one;

2-[(2,6-Difluoro-phenylamino)-methylene]-5-quinolin-6-ylmethylene-thiazolidin-4-one;

[2,4-Dichloro-5-(4-oxo-5-quinolin-6-ylmethylene-thiazolidin-2-ylideneamino)-phenoxy]-acetic acid;

2-[2,4-Dichloro-5-(2-methoxy-ethoxy)-phenylimino]-5-quinolin-6-ylmethylene-thiazolidin-4-one;

4-Chloro-3-(4-oxo-5-quinolin-6-ylmethylene-thiazolidin-2-ylideneamino)-benzoic acid; and

[2,4-Dichloro-5-(4-oxo-5-quinolin-6-ylmethylene-thiazolidin-2-ylideneamino)-phenoxy]-acetic acid,

or a salt thereof.

Assignments (2)
CHANGE OF NAME Recorded Feb 18, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023954/0579 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2006
From: HASEGAWA, MASAICHI; TANG, JUN; SATO, HIDEYUKI
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 017459/0195 →
Continuity (2)
Provisional Application 6042838400 · Nov 22, 2002
Related Publication 20060293338A1 · Dec 28, 2006